Abstract render of several peptide chains converging into one droplet, representing a multi-peptide research blend
Mindful Research

Multi-Peptide Research Blends: Terminology and Composition Conventions

Updated By: Mindful Research Team4 min read

Key takeaways

  • A research blend is a defined co-formulation: named peptides at listed masses, co-lyophilized in one vial.
  • Describe a blend by its components, with CAS numbers and masses, never by the catalog name alone.
  • Mass composition and molar composition are different things; report the one that matters for the experiment, usually molarity.
  • Identity and purity are properties of each component, so a blend COA carries one set of values per peptide.
  • For in vitro research use only.

A multi-peptide research blend is a defined co-formulation of two or more named synthetic peptides, each at a listed mass, combined and lyophilized in a single vial; it is described by its components and their CAS numbers, reported by the molarity of each component, and certified by one identity and one purity value per peptide. This guide sets out the vocabulary and the conventions, using the catalog's blends GLOW and KLOW as the worked examples.

What counts as a research blend?

Three things have to be true. The components are named peptides with their own identifiers; the mass of each per vial is listed; and the components are physically combined before lyophilization, so that one vial yields one solution with a fixed ratio. GLOW (BPC-157, TB-500 and GHK-Cu, 70 mg) and KLOW (the same three plus KPV, 80 mg) meet all three. The older two-component BPC-157/TB-500 blend is the same idea with two peptides.

What a blend is not: it is not a new molecule, it has no sequence or CAS number of its own, and the catalog name is a label for the composition rather than a chemical descriptor.

Why "blend" and "co-formulated" rather than other words?

Vendor pages and forums sometimes describe multi-peptide vials with a word borrowed from bodybuilding slang. That word carries an implication of combining products for an effect in a person, which is outside the in vitro frame in which these materials are supplied, and it also fails as a description: it says nothing about which peptides, at what masses, in what ratio. "Blend" and "co-formulation" are the terms used in formulation chemistry for exactly this kind of defined mixture, and they are the terms used throughout this catalog and these guides.

How is composition described: by mass or by molarity?

Both, but for different purposes. Mass composition (10 mg + 10 mg + 50 mg for GLOW) is what the vial label and the COA state, and it is what the laboratory weighs out, in effect, when it reconstitutes the vial. Molar composition is what the cells in an assay experience, and it can look nothing like the mass ratio when the components' molecular weights differ a lot. GLOW is 1 : 1 : 5 by mass but roughly 3.5 : 1 : 62 by molarity, because GHK-Cu (402.92 g/mol) is so much lighter than TB-500 (4963 g/mol). The arithmetic is in the GLOW 70 mg concentration-math guide.

Convention Use it for Example (GLOW in 2 mL)
Mass per vial Label, COA, ordering 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu
Mass concentration Stock preparation 5, 5 and 25 mg/mL
Molar concentration Assay design and reporting 3.5 mM, 1.0 mM and 62 mM

How should a blend be written in a methods section?

By component. A reproducible description names each peptide with its CAS number, gives the mass per vial from the lot COA, states the reconstitution volume, and gives the final molarity of each component in the assay. "GLOW, 10 µg/mL" is not reproducible; "BPC-157 (CAS 137525-51-0) 3.5 µM, TB-500 (CAS 77591-33-4) 1.0 µM, GHK-Cu (CAS 89030-95-5) 62 µM, from a co-formulated vial, lot X" is. Where a blend is compared with single peptides, the single-peptide arms are run at the same molarity as that component in the blend.

How is a blend certified?

One identity and one purity value per component. The COA for a three-peptide blend should carry three HPLC purities and three mass-spectrometry identities, so that the reader can confirm each peptide is present at the expected mass. A single number for the vial cannot show that. The specific checks are in verifying a multi-component blend COA; the general reading guide is reading a COA line by line.

Naming conventions in this catalog

Catalog blend names (GLOW, KLOW) are short labels. Each product page lists the components, their masses, CAS numbers, formulas and molecular weights, and the guides for each blend start by expanding the label into its composition: see what is GLOW peptide and what is KLOW peptide. When a query uses a variant such as "GLOW blend" or "GLOW blend peptide", it refers to the same composition.

Related research guides

Research-use note

All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.

Frequently asked questions

What is a peptide research blend?

A peptide research blend is a defined co-formulation of two or more named synthetic peptides, each at a listed mass, combined and lyophilized in a single vial for in vitro research. View the GLOW blend

Why is the term blend used rather than other words?

Because blend describes a defined mixture with listed components and masses, which is what the vial is. Words borrowed from forum usage imply combining products for an effect in a person, which is outside the in vitro frame.

How should a blend be written in a methods section?

List each component with its CAS number, the mass per vial from the COA, the reconstitution volume and the final molarity of each component.

What is the difference between a blend and a single peptide product?

A single-peptide vial has one sequence, one CAS number and one purity value. A blend has one of each per component, and a ratio.

Are research blends for human or animal use?

No. They are supplied for in vitro laboratory research use only.